Glen Wakeman helping entrepreneurs avoid pitfalls

Glen Wakeman is CEO and founder of LaunchPad Holdings LLC. Wakeman’s firm provides up and coming CEO’s with software that will help turn their ideas into a working plan. Glen Wakeman is best known for his work in the business and financial industries. As his career progressed, Wakeman decided he wanted to share his insider knowledge and guidance to up and coming entrepreneurs. Glen Wakeman gained a large following and has taken to social media to offer up his experience and knowledge. Along with his social media presence, he also runs a popular blog, which is used to discuss importance of running a company successfully. Learn more about Glen Wakeman at Crunchbase.

Glen Wakeman is best known for his work for LaunchPad Holdings LLC, which is a company that produces software that helps new business leaders turn their ideas and dreams into a workable plan. Glen Wakeman attended college at the University of Scranton, where he earned two undergraduate degrees in Finance and History. He later attended the University of Chicago, where he received his Masters of Business Administration. His lengthy career began at GE Capital and lasted for more than 20 years. Glen Wakeman eventually became the CEO of GE Money Latin America. Wakeman managed to turn the company into #12 billion assets and 17,000 employees. It currently operates in nine countries. Visit to know more about Glen Wakeman.

Through Glen Wakeman’s storied career, he has lived and worked in six different countries all throughout Europe, Asia and South America. He oversaw operations in 30 different regions. As he continued his success, he gained global recognition as a writer, inventor, investor, mentor and international business leader. While at GE Capital, he was able to found Nova Four, which helped paved the way for LaunhPad. Glen Wakeman continues to offer up guidance to those in need.

Glen Wakeman is a man who likes a challenge and is currently looking for a new one. Wakeman has recently discovered machine learning, and the possibility of using it to solve business problems. Wakeman says that machine learning can create decision making by expanding quality. Glen Wakeman continues to grow his success in the business and financial world.


Oncotarget Helps Oncologists Connect with Each Other

Since Oncotarget first started, oncologists who use the publication have been able to make valuable connections. Not only are they part of a community where they can work together, they are also able to learn more about the things they can do to make everything better for their clients. The point of the publication is to provide feedback and advice on different things the patients need and that has helped Oncotarget to make the right choices. The publication knows how they can connect with others and they know it is important to make sure people are doing what they can with each other. They are also better prepared for making things easier on their clients and that has gone back to where they first started. Everything the company does is for their clients and the evidence is in the patients getting the treatment they need in different ways that others had not thought of before. Learn more about Oncotarget at Research Gate.

While Oncotarget has continued to work to make sure they are providing information on different treatment options, they know what it takes to be a big part of the cancer treatment community. In addition, the publication has always done their best to provide information on the options other doctors may not have been able to find in the past. It has helped them make sure they are doing things right and they are providing patients with everything they need to do better. They want to see their patients heal instead of having to worry about all the issues that come with cancer treatment. Visit Oncotarget’s profile page at

When Research Gate published information about Oncotarget, they knew they were doing things the right way. They were prepared to help their clients so they wouldn’t have to worry about the issues that came from cancer treatment. The publication saw Oncotarget as a gamechanger for cancer treatment. Oncotarget was used to help people reach the goals they wanted but it was also used to make sure people were getting everything they needed so they could be more successful in different areas of business and with different things they could do to see how the business was going to work.

Learn more:

Talkspace: Bringing Therapy Closer Home

With the internet here with us, finding essential services is as easy as clicking on a button. There are many people who rely on the internet for almost everything. Not only does the internet have pros, but it also has its cons. One of the disadvantages of the internet is that it has promoted the seclusion of people. Studies show that most of the teenagers on online platforms suffer from one form of depression or another.

One of the innovative ways of helping depressed people is by using internet as a therapy platform. People suffering from depression are usually victims of stigma, and getting medical help is usually a last resort. In order to help such people, e-therapy platforms such as Talkspace have mushroomed in the recent past.

If you are afraid of being victimized or stigmatized because of your mental illness, having an online therapist is one of the best solutions you can find. You have the flexibility of talking to a professional from the comfort of your home or workplace. Above all, you can maintain your anonymity.

How Does Talkspace Work?

Talkspace offers a wide range of therapy services for people suffering from depression. Once you sign up for their app, you will be prompted to choose a plan that fits your budget. The experts will also match you with a caregiver who matches your unique needs. The good news is that all their therapists are licensed caregivers.

Communicating with your therapist is something which you can do when you are in the mood to do so. You can also schedule messaging times with your caregiver. The therapists strive to create enough time for their patients, and you should expect regular responses from them. Their customer support team is also more than ready to answer all your questions about their services.

Jorge Moll: Understanding the Science of Giving

Jorge Moll, a Brazilian neuroscientist, along with his colleague, Jordan Grafman, decided to experiment on the human brain. They invited several volunteers and asked them to imagine a scenario where they would be giving a tremendous amount of money to the charity they wanted and another situation where they would be keeping the money for themselves. The two neuroscientists who are working on the research were surprised to see the results of their study. It shows that when people are imaging things related to charity and generosity, a small area of the brain becomes activated, sending pleasurable signals that are comparable to eating or having sex. During the experiment, they found out that giving and charity is innate to the human brain, and that people would feel something good because of the signals sent by the brain. Learn more about Jorge Moll at Google Scholar.

The study conducted in 2006 supports what other religions are stating, that giving is much better than receiving. Jorge Moll and other neuroscientists around the world are performing the studies concerning on morality and its correlation with science. They wanted to know why doing something right is better, and they tried to prove it with scientific facts. In the span of the research about morality, Jorge Moll and his colleagues found out that the human brain evolved while keeping its moral compass intact. It is the reason why doing something good feels much better.


Despite the advancement in medicine and technology, neuroscientists are still baffled about how the human brain works, and what will happen if is used to its full capacity. The mystery of morality is just one of the many mysteries surrounding science, and neuroscientists are slowly unlocking its secrets. Jorge Moll and his colleagues would continue doing experiments involving morality, and they wanted to find out more information about the trait naturally to all human beings. However, there are already groups who are protesting the experiment done by the neuroscientists. These people fear that by allowing scientists to conclude about what’s going on inside the brain, the idea of free will would merely be forgotten, and the moral basis of doing what is right or wrong would only depend on brain chemistry. Know more about Jorge at Crunchbase.

Highland Capital Latest Financial Endeavor

Dallas-based Highland Capital Management L.P. has moved their objective of increasing access to financial opportunities in Asia forward. Through their subsidiary Highland Capital Management Korea Ltd., Highland finalized a healthcare-focused private equity fund with the National Pension Service (NPS) of South Korea.

The fund is valued at $499.8 billion with a total capital commitment from Highland of $147 million. That is an significant amount. Highland will be working with Korean private equity and venture capital firm, Stonebridge Capital. This strategy is keen for opening the market of accessibility to countries such as South Korea, China, and the United States. Read this article at

According to managing director and co-head of Highland’s private equity group, Carl Moore, the largest industry exposure has been healthcare for the past 15 years. This strengthens their credibility, expertise, and precision in this field.

According to Matt Jameson, managing director of private equity at Highland Capital Management, believes the healthcare industry will encounter, more or less, “disruptive forces” that will gravely affect middle market companies. What better way to get in front of a disruption then getting involved and increasing your exposure, setting up your company’s position to influence the trend, cultivate the movement. Ultimately, this helps the clients achieve their goals. Visit to know more.

Highland Capital Management L.P., founded in 1993, is an established SEC-registered investment adviser who has, cumulatively, roughly $14.0 billion of assets under management (AUM).  For example, they are experts at distressed and special situations private equity, collateralize loan obligations (CLOs), separate accounts and long-only funds, and credit hedge funds.

Highland has myriad of clients which include governments, foundations, public pension plans, endowments, financial institutions, corporations, fund of funds, and individuals with substantial net-worth.

Always thinking of their employees, Highland Capital Management and their partners have invested over $10 million in the communities where their workers live and work since 2005.


Women in Music; Desiree Perez

This article is about women in music from the 2017 billboard music lists. The women in music have done many things like discovering talent, negotiating contracts, and securing rights. The female executives who are listed on the 2017 list demonstrate the best of the tastemakers, dealmakers, and influencers.

One of the such women is Desiree Perez. Perez is forty-seven years of age and is the chief operating officer of a company by the name of Roc Nation. Roc Nation is an entertainment company based in America. Her reputation is one of a tough negotiator. She proved this by making a $200 million Sprint investment with TIDAL. This was announced in January.

That particular deal had been fully paid five months later. This was with Jay-Z’s “4:44” his fourteenth album that was his Billboard 200 No.1 album. Sprint actually gave a free download to one million people. This got the MC a platinum plaque previous the album came out.

Since then the album has been serving as the crown jewel of an impressive looking marketing campaign. This album has racked up equivalent album units as 600,000. Also, in April an equity partner called Live Nation had signed long-term and new $200 million partnership that toured with Jay-Z. This was ahead of the ten-year anniversary in 2018. This tour was sponsored by Puma, which was 21 percent higher than the 2013 Magna Carter Tour.

Now some more general information about Desiree Perez. Perez is currently surrounded with very successful people of the industry. This is largely due to the fact that she has been assisting Jay-Z for a total of twenty-two years. Carter’s giant conglomerate company, It has encompassed talent development, music production, and concert tour management as well. She has been in control of taking control of everything at the same moment she makes sure the shareholders have their profits. To know more about her click here.

Perez has worked for ROC since 2009 as the Chief Operating Officer. Most of the areas she has worked on was management, labeling, and publishing operations. One cool thing she has done was taking part with Rihanna in a Samsung deal.

How Organo Gold Coffee Boosts Brain Health

The world enjoys, on average, 1.6 billion cups of coffee every day, and Organo Gold is recognized for some of that demand. The company blends premium coffee with the Asian Reishi mushroom, creating a healthier beverage. This mushroom is part of traditional Chinese medicine in East Asia, and has been used for over 3000 years. Watch this video on Youtube.

90 percent of people around the world use caffeine in some form, and the founder of Organo Gold, Bernardo Chua, knew coffee consumption offered a wide range of health benefits that went far beyond providing a boost in the morning. Researchers have acknowledged that coffee can encourage cardiovascular health, and shows signs of reducing exposure to various cancers. In fact, recent studies show that coffee has more conveniences like drinking at least 1-2 daily cups can boosts cognitive function, and diminish the exposure to intellectual decline, including Alzheimer’s disease. Clinical studies reveal people who enjoy a high consumption of coffee, on a daily basis, had a significant 27 percent reduction in their risk of developing Alzheimer’s disease, compared to those that do not drink coffee.

How Does It Work?

  • Coffee contains thousands of components in addition to caffeine.
  • One of the most effective, active ingredients in coffee is Chlorogenic acid, which has an active role in guarding against cognitive decline.
  • The Reishi mushroom has a large amount of unsaturated acids, natural alkaloids, abundant polysaccharides and minerals that nourishes the body, and reinforces the immune system.

Together, Organo Gold has created a unique blend of one of the most intriguing beverages that benefits the bodies in numerous ways.


Celebrating Milestones

Organo Gold has a long history of success and opportunity. The company marked their 10th anniversary this year. Operating in more than 50 countries, the company has evolved from premium coffee to several beverages including green and red teas, cafe latte, and hot cocoa, and personal hygiene products. One thing is for sure, their blend of healthy coffee is preparing us for the future. Visit to know more.

Branching Out with TalkFusion

TalkFusion is a firm that offers video email products as well as Live Meetings. Live Meetings allows businesses to make presentations by video conferencing with each other. TalkFusion was founded by Bob Reina in 20117 after he figured out that video email was possible. Since the company opened it become one of the foremost leaders in video emailing and conferencing.

Some of the services that TalkFusion offers businesses and individuals are video emails, video conferencing, video newsletters, live meetings, video chatting, and sign up forms. With these services, businesses and individuals can get more work done more efficiently and effectively. TalkFusion is taking the world by a storm and in the following article, TalkFusion has opened a new office in India.

The new office of TalkFusion is located in the city of New Delhi. It will become the central marketplace for all of TalkFusion’s Indian operations. The new office is called TalkFusion India, Pvt Limited. The expansion of TalkFusion in India is not new. Many people in the Indian market have already spread the word about the company. Bob Reina wants to make sure that this new office runs as smoothly as possible.

Development of new products and expansion into new markets are two of the key prospects for the company. With Bob Reina and an experienced staff at the helm, TalkFusion can remain one of the most competitive company out there when it comes to video email and conferencing. This is the way Bob Reina likes it.

Dr. Clay Siegall, founder of Seattle Genetics

Dr. Clay Siegall is the CEO and founder of Seattle Genetics. Founded in 1998, Seattle Genetics is a biotech firm specializing in the developement of therapy drugs for diseases with high mortality rates that have not seen a decrease in decades. Dr. Siegall has lead his firm in the targeted threapy industry. He invented the first FDA-approved antibody drug conjugate. He has partnerships with such drug manufacturers as Bayer, Pfizer, Genentech and several more. Dr. Siegall has a B.S in zoology from the University of Maryland and a Ph.D from George Washington University in Genetics. Seattle Genetics has become a leading power player in cancer research under Dr. Siegall’s leadership.

Dr. Clay Siegall specifically became interested in alternate cancer fighting drugs when a close relative was diagnosed with cancer. It was not the cancer that nearly killed this relative, it was the chemotherapy and annemia that they developed. This is what prompted Dr. Siegall to search for another way. Combined with him being a self confessed work-aholic, he decided to leave Bristol and start up Seattle Genetics. The first ten years of Seattle Genetics was financially insecure. Operating capital was being depleted and having a drug approved by the FDA can take quite a few years. The first drug the FDA approved was conjugate and and this was the first ADC ever approved by the FDA. Seattle Genetics gains clients through a talented sales staff.

In January of 2013 Mirna Therapeutics announced the appointment of Dr. Siegall as an outside director to is board of Directors. Mirna Therapeutics is a biotechnology company focused on the developement and commercialization of microRNA therapeutics. He also serves on the board at Alder BioPharmaceuticals. Alder BioPharmaceuticals is a private biotechnology company. Dr. Siegall has secured Seattle Genetics more than $675 million through private and public financings. He has written more then seventy publications and currently has over fifteen patents

Following Dr. Siegall’s Successful Career in Biotech

For those who keep up with medical news, Dr. Clay Siegall is a familiar name. Dr. Siegall is currently the CEO of a company which he also founded, Seattle Genetics. Seattle Genetics is a biotech firm, which is located in Seattle. They specialize in therapy drugs for diseases that are life-threatening, and which do not have a cure. An example of the therapy drugs which the firm develops is cancer medication.

Educational Background and Career

Siegall studied zoology at the University of Maryland, where he also earned his B.S. degree. He is also a Ph.D holder from George Washington University, where he did his research in genetics. After completing his studies, Dr. Siegall decided to establish his own firm, and make contributions to the field of biotechnology. This is where the idea to found Seattle Genetics came about. The firm was finally launched in 1998.

With his experience and leadership skills, Dr. Siegall has managed to lead Seattle Genetics to great heights. One of the milestones which the firm has made is developing a drug that was approved by the FDA as an antibody conjugate. The firm has also developed well over 20 drugs as a result of their collaboration with various manufacturers in the industry. Their partners in the biotech sector include Pfizer, Genentech, Bayer and many other drug manufacturers.

When asked about how he brings his business ideas to life, Dr. Siegall attributes his success to his passion for medicine and technology. He considers technology as one of the best interventions in medicine. With the help of technology, patient can get the right diagnosis as well as treatment.

Clay Siegall was also inspired to start his business after a family member suffered from cancer, and almost died. He realized that the issue was not really triggered by the cancer, but by the effects of chemotherapy. By developing a drug that would help patients combat these side effects, their quality of life is improved. For Dr. Siegall, working on more drugs to help the sick will continue to be his passion.